Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001172273 | SCV001335313 | pathogenic | RASopathy | 2020-03-24 | reviewed by expert panel | curation | The c.1796C>T (p.Thr599Ille) variant in BRAF was absent from large population studies (PM2; gnomad.broadinstitute.org). It has been reported as a de novo occurrence with parentage confirmed in 1 proband diagnosed with cardiofaciocutaneous syndrome (PS2, PS4_Supporting; PMID 30732632). This variant was also observed as a de novo occurrence without parentage confirmed in proband with phenotypic features of a RASopathy but no clinical diagnosis (PM6; GeneDx internal data, SCV000057239.11). The variant occurs in the CR3 activation domain of BRAF, which has been defined by the ClinGen RASopathy Expert Panel as a region important for protein function (PM1; PMID 29493581). Computational prediction tools and conservation analysis suggest that the p.Thr599Ile variant may impact the protein (PP3). The variant is located in the BRAF gene, which has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants and pathogenic missense variants are common (PP2; PMID: 29493581). Of note, this variant has also been observed in association with somatic malignancies; however, analysis and classification of somatic variation is currently not used to inform germline classifications for the RASopathies. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant RASopathy based on RASopathy-specific ACMG/AMP criteria applied (PMID:29493581): PS2, PS4_Supporting, PM1, PM2, PM6, PP2, PP3. |
Gene |
RCV000033334 | SCV000057239 | pathogenic | not provided | 2022-01-28 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33482860, 30732632, 24957944, 15488754, 16439621, 15520807, 17603483, 29493581) |
Institute of Human Genetics, |
RCV001705626 | SCV001934482 | likely pathogenic | Cardiofaciocutaneous syndrome 1 | 2021-03-15 | criteria provided, single submitter | clinical testing | |
Database of Curated Mutations |
RCV000433036 | SCV000505585 | likely pathogenic | Melanoma | 2015-07-14 | no assertion criteria provided | literature only | |
Database of Curated Mutations |
RCV000440873 | SCV000510426 | likely pathogenic | Neoplasm | 2016-05-13 | no assertion criteria provided | literature only | |
Service de Génétique Moléculaire, |
RCV000824927 | SCV000965959 | uncertain significance | Noonan syndrome | no assertion criteria provided | clinical testing |